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POST-MENOPAUSAL METRORRHAGIA – AN OVARIAN
THECOMA PRESENTATION
METRORRAGIA PÓS-MENOPAUSA – UMA APRESENTAÇÃO DE
TECOMA OVÁRICO
Alexandre Batista1, Teresa Margarida Cunha2
Resumo
Os tecomas são tumores raros do ovário, do
grupo dos tumores dos cordões sexuais, de
natureza sólida e frequentemente unilaterais.
Têm maior incidência no período pós-
menopausa e normalmente são silenciosos.
Quando sintomáticos traduzem-se por dor
pélvica e metrorragia (condicionada pela
habitual natureza produtora de estrogénios do
tumor). Podem ser concomitantes a síndrome
de Meigs e/ou de Golin-Goltz e associarem-
se a transformação benigna ou maligna do
endométrio. Embora a ecografia possa ser
inespecífica neste contexto, uma avaliação
multiparamétrica abrangente em ressonância
magnética, incluindo por estudo dinâmico e
com ponderação em difusão, permite
frequentemente orientar de modo favorável a
marcha diagnóstica.
Apresentamos um caso raro de tecoma do
ovário, com espessamento associado do
endométrio, avaliado por ecografia
ginecológica por vias supra-púbica e
transvaginal bem como tomografia
computorizada e ressonância magnética,
confirmado cirurgicamente. Tratou-se de uma
examinada caucasiana de 61 anos de idade,
apresentando-se com metrorragia pós-
menopáusica, sem outros sintomas nem
contexto familiar relevante. Procedeu-se, a este
propósito, a uma revisão da literatura focada
no diagnóstico multimodal diferencial,
apresentação clínica, tratamento e prognóstico
destes tumores.
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Abstract
Thecomas represent rare, solid sex-cord stromal
ovarian tumors, often unilateral, asymptomatic
and occurring in postmenopausal patients.
When symptomatic, they most commonly
present with pelvic pain and metrorrhagia (due
to their frequent estrogenic releasing nature).
Thecomas can occur concomitantly with Meigs
and/or Golin-Goltz syndrome and may also
be associated with benign or malign
endometrial transformation. Although
gynecologic transabdominal and transvaginal
ultrasound can be quite unspecific in this
particular solid ovarian tumor presentation,
magnetic resonance imaging including
diffusion and dynamic data can frequently
suggest the diagnosis and significantly facilitate
the diagnostic work-up.
We report a rare case of  ovarian thecoma, with
concomitant endometrial thickening,
demonstrated by gynecologic transvaginal
ultrasonography, computed tomography and
magnetic resonance contrasted imaging,
surgically confirmed. The patient was a 61 years
old caucasian female presenting with
postmenopausal metrorrhagia, without other
associated symptoms nor family medical
context. On this regard, we performed a review
of the literature, focused on multimodal
differential diagnosis imaging, clinical
presentation, treatment and prognostic of this
pathological finding.
Key-words
Thecoma; Ovary; Ultrasound; Computed
Tomography; Magnetic Resonance.
ACTA RADIOLÓGICA PORTUGUESA
Setembro-Dezembro 2014  nº 103 Volume XXVI  61-65
Clinical history
61 years old caucasian female patient presenting with
postmenopausal metrorrhagia for a period of four months,
without other associated symptoms and with no relevant family
medical context. The patient was not on hormone replacement
therapy. Physical examination was unremarkable, with no evident
abdominal or pelvic masses, nor localized pain. Laboratory
findings included an elevated CA 125 value (86,7 U/ml), normal
CEA (0,9 ng/ml) and CA 19.9 (11,8 U/ml), and normal
hemoglobin (13,2 g/dL) and hematocrit  (37,8%).
Image findings
Outside our Institution the patient underwent gynecologic
transabdominal and transvaginal ultrasonography (TVUS) that
revealed a solid right ovarian mass, heterogeneous, mostly
hypoechoic, measuring 108 x 71 mm (Fig. 1-A). Concomitantly
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The patient was then referred to our Department and evaluated
through a dedicated pelvic magnetic resonance (MR) study,
revealing an exofitic solid growth originating in the posterior
wall of  the right ovary, measuring 110 x 100 x 80 mm (craneo-
caudal x latero-lateral x antero-posterior maximum diameters).
The tumor had regular and well delimited contours,
demonstrated isosignal with adjacent muscle on T1 weighted
images and discrete hypersignal on T2 weighting. There were
intratumoral regions of high cellularity with diffusion restriction,
as observed on the b = 1000 s/mm2 images and apparent
diffusion coefficient (ADC) map. The dynamic tumoral
evaluation showed gradual gadolinium uptake, including in
the interstitial late phase (180 seconds post injection), in a type
1 time-signal intensity curve [1], with evident hypovascularity
comparing with the more avid arterial enhancement of adjacent
myometrium. Additionally, a probable endometrial polyp with
76 x 43 x 17 mm (craneo-caudal x latero-lateral x antero-posterior
maximum diameters) was observed. There was also a small
amount of free intraperitoneal fluid within the recto-uterine cul
de sac (Figs. 3-10).
These findings, in agreement with the presenting clinical history
and laboratory values, suggested primarily a thecoma.
Hysterectomy with bilateral salpingo-oophorectomy was
performed. On macroscopy, the tumor was solid, with uniform
an endometrial thickening of  12,5 mm was noted (Fig. 1-B).
There was a discrete volume of free fluid in the right ovarian
fossa. There were no enlarged pelvic lymph nodes.
Subsequently, a computed tomography (CT) scan with i.v.
administration of iodinated contrast media was performed,
confirming the previously identified right adnexal mass (with
mild vascular enhancement on venous phase) and endometrial
thickening (Fig.2). No pelvic or para-aortic lymph node
enlargement was identified.
A
B
Fig. 1 - Transvaginal ultrasonography. Right adnexal mass, heterogeneous,
mostly hypoechoic, measuring 108 x 71 mm (yellow arrow). Concomitant
endometrial thickening of 12,5 mm (white arrow).
Fig. 2 - Computed tomography scan with i.v. administration of  iodinated
contrast media (venous phase). Well delimitated right adnexal solid
mass with mild vascular enhancement. Endometrial thickening can also
be detected (white arrow).
Fig. 3 - Axial T2-weighted magnetic resonance. Right adnexal tumor
with well defined contours and discrete hypersignal on T2-weighted
sequence. Note the endometrial thickening and a small amount of free
fluid in the recto-uterine recess (white arrow).
Fig. 4 - Axial T2-weighted magnetic resonance. This image shows
evidence of the beak and the embedded signs regarding the tumor-
posterior ovarian wall interface (white arrow).
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texture (excluding a few cystic spaces), well-circumscribed, and
measured 120 x 110 x 70 mm. Sectional analysis of the tumor
revealed a yellow and fascicular mass (Fig.11). The tumor had
more than 80% of its cellular content positive for alpha-inhibin
and a low proliferation index (<10%). There were two
endometrial polyps (40 and 30 mm of maximum diameter).
The pathological findings were consistent with thecoma.
Discussion
Thecomas represent rare, solid sex-cord stromal ovarian tumors,
accounting for approximately 0.5 – 1% of all primary ovarian
A
B
Fig. 5 -  Coronal (A) and sagital (B) T2-weighted magnetic resonance
depicting normal left ovary appearance (white arrow).
Fig. 6 - Axial T1-weighted magnetic resonance. The mass demonstrates
isosignal with adjacent muscle on T1-weighted sequence.
Fig. 7 - Fat-suppressed axial T1-weighted MR image after gadolinium
administration (arterial phase). There is little mass enhancement
comparing to myometrium.
Fig. 8 - Fat-suppressed axial T1-weighted MR image after gadolinium
administration (intersticial phase). Gradual gadolinium uptake with
discrete enhancement in the interstitial late phase (180 seconds post
injection), in a type 1 time-signal intensity curve, revealing the lesion´s
fibrin rich territory.
Fig. 9 - Fat-suppressed axial T1-weighted MR image after gadolinium
administration. Type 1 time-signal intensity curve, commonly seen in
benign lesions.
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ovarian medulla and should be considered apart form fibromas,
which originate from the cortex [4]. Although being
uncommon, they represent the most frequent solid primary
ovarian tumor [5].
Thecomas of the ovary can present with pleural effusion or
ascites (Meigs syndrome) and may also be associated with basal
cell nevus Golin-Goltz syndrome (large bilateral fibrotic ovarian
tumors, basal cell carcinomas of the skin, odontogenic
keratocysts and other abnormalities) [6], though they usually
are asymptomatic, and when symptomatic, they are most
commonly manifested by pelvic pain and metromenorrhagia
(due to their frequent estrogen releasing nature) [7,8].  Estrogen
stimulation by a pre-existing thecoma may also induce the
development of endometrial hyperplasia and endometrial
polyps and presumably induce mesenchymal and mixed
epithelial / mesenchymal uterine tumors, namely adenosarcoma
[9, 10].
They are often unilateral and occur in postmenopausal patients
but can develop in younger patients (mean ages in the fifth and
sixth decades) [11, 12]. As most adnexal tumors do, the
laboratory workup on a thecoma presentation can reflect elevation
of particular tumor markers, such as CA-125 [13].
Histologically thecomas are similar to theca interna cells of the
ovary and have a mixed lipid and colagenic composition, the
later derived from spindle, oval or round cells [6].
The management approach to thecomas is surgical in larger
lesions, with excellent prognosis as they are mainly benign
tumors [14].
TVUS is commonly the first choice imaging modality for
suspected pelvic tumor, due to its easy access and safety profile,
nonetheless being often non specific. Thecomas usually present
as a solid mass or, if larger, predominantly solid with few cystic
areas, being the solid component iso or hypoecogenic in relation
with adjacent stroma, frequently with significant posterior
attenuation, without identifiable tumoral calcification.  On color
Doppler evaluation thecomas usually have neglectable vascularity
[9, 15]. On CT evaluation tumor attenuation is often similar to
adjacent myometrium, with evident hypovascularity on arterial
phase enhancement study, sometimes being evident progressive
delayed contrast uptake due to fibrin rich tumoral areas [11].
This same fibrous tumoral component is responsible for the
low T1-weighted and very low T2-weighted MR signal
(excluding scattered areas of high signal intensity corresponding
to cystic or edematous change) [5, 11]. If fatty elements are
present, they can be identified as hyperintense on T1-weighted
and translate in a decreased signal intensity on selective fat-
saturation or out-of-phase gradient echo sequences [9]. On
diffusion-weighted imaging (DWI), most thecomas display
intermediate signal similar to that of myometrium,  attributable
to their cellular content of fibroblasts and thecal cells, but lower
than the usually observed in malignant, high cellular ovarian
tumors. The ADC of thecomas and other adnexal masses has
no described relevant difference, although the ADC of thecomas
has been reported to be significantly lower than that of
leyomiomas [16].
The differential diagnosis of ovarian thecoma primarily
encompasses masses with a fibrous component, as uterine
leyomioma, Brenner tumor and mature cystic teratoma [17].
When considering uterine leyomioma, the most common pitfall
lies in broad ligament leyomioma and pedunculated leyomioma.
However, their origin can usually be traced, namely due to the
Fig. 11 - Tumor macroscopic surface section. Two sections of  the right
oophorectomy specimen revealed a yellowish tone and fascicular solid
mass.
neoplasms [2]. Ovarian sex cord tumors are those who arise
from granulosa, theca, Leydig, Sertoli or stromal fibroblast cells
[3]. Notwithstanding sometimes having an interspersed fibrous
component, thecomas are presumably originated from the
A
B
Fig. 10 - Diffusion-weighted MR image. Intratumoral areas of  high
cellularity with diffusion restriction, as observed in the
b = 1000 s/mm2 images (A) and apparent diffusion coefficient (ADC)
map (B), revealing the tumor´s mixed theca cells and fibrous
composition.
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bridging vascular sign [18], that clarifies their feeding by uterine
arteries, opposed to thecomas, supplied by ovarian arteries or
ovarian branches of uterine arteries [17].
Brenner tumours are usually very small (<2 cm) and benign
epithelial ovarian lesions, mostly composed of fibrous dense
tissue and urothelium-like transitional cells. They most
commonly present as a multilocular cystic tumor or a smaller
predominantly solid mass. Their dense fibrous stroma has low
signal on T2-weighted MR imaging, and an expected gradual
gadolinium uptake. Usually they comprise extensive amorphous
calcifications [19]. Their small size compared to the median
thecoma size of approximately 13 cm, more prominent
calcifications and extensive cystic component usually allows the
differential diagnosis [9].
Mature teratomas most frequently occur in pre-menopausal
women, and present as a unilocular cystic tumour (in 88% of
the cases), filled with sebaceous content and lined with
epithelium. Due to their origin in two or more germinal layers,
they can contain hair and teeth, that when present are commonly
encompassed by a wall protuberance (the Rokitansky nodule or
dermoid plug) [20]. The most common imaging US features
for mature teratoma are the presence of a cystic lesion with a
densely echogenic shadowing mural nodule (dermoid plug); an
ecogenic (sebaceous) mass with very strong posterior attenuation
(“tip of the iceberg” sign) and a dermoid mesh, with multiple
thin echogenic lines (hairs) passing within the cyst. On CT and
MRI imaging, macroscopic fat within a cyst, with or without
mural calcification, is diagnostic. Less common monodermal
dermoids include struma ovarii (with a predominance of thyroidal
tissue) and carcinoid [21].
Our patient presented with a predominantly solid right adnexal
mass, hypoechoic on ultrasound, with regular and defined
contours and no evident vascularization on color Doppler. On
MRI interrogation the tumor showed to be originated from
the posterior right ovarian wall, had gradual intersticial
enhancement, revealing its fibrous component, and small
pockets of cellularity in DWI. There was no accompanying
significant ascites, peritoneal lesions or pelvic enlarged lymph
nodes. There was also an endometrial polyp. These findings, in
a postmenopausal metrorrhagia context, and in conjunction
with the described clinical and laboratory data suggested primarily
a thecoma, with mixed theca cells and fibrous composition and
expected estrogenic endometrial effect.
The lesion was surgically confirmed as thecoma.
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